GlassScriptPhysician profile
Brooke Saffren
NPI 1518547371
$972.36
in general payments reported to CMS, 2019-2025
8 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $109 · 2022: $34.82 · 2023: $419 · 2024: $410.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $829.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $828.84 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $397.47 | 2023-2024 | Clareon, Hydrus Microstent |
| Merz Pharmaceuticals, LLC | $159.82 | 2022-2023 | Xeomin |
| Mallinckrodt Hospital Products INC. | $126.02 | 2024 | Acthar |
| Amgen INC. | $119.85 | 2024 | Tepezza |
| Horizon Therapeutics Plc | $108.70 | 2021 | |
| Abbvie INC. | $22.41 | 2024 | |
| Oyster Point Pharma, INC. | $20.41 | 2023 | Tyrvaya |
| Apellis Pharmaceuticals, INC. | $17.68 | 2023 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Brooke Saffren listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.